Incorporating (18)FDG-PET-defined pelvic active bone marrow in the automatic treatment planning process of anal cancer patients undergoing chemo-radiation

BACKGROUND: To investigate whether the incorporation of (18)FDG-PET into the automatic treatment planning process may be able to decrease the dose to active bone marrow (BM) for locally advanced anal cancer patients undergoing concurrent chemo-radiation (CHT-RT). METHODS: Ten patients with locally a...

Descripción completa

Detalles Bibliográficos
Autores principales: Franco, Pierfrancesco, Fiandra, Christian, Arcadipane, Francesca, Trino, Elisabetta, Giglioli, Francesca Romana, Ragona, Riccardo, Ricardi, Umberto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Technical Advance
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5668955/
https://www.ncbi.nlm.nih.gov/pubmed/29096619
http://dx.doi.org/10.1186/s12885-017-3708-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5668955/
https://www.ncbi.nlm.nih.gov/pubmed/29096619
http://dx.doi.org/10.1186/s12885-017-3708-4

Ejemplares similares